OCERA THERAPEUTICS INC

Profile

Company Names

OCERA THERAPEUTICS INC

Addresses

12651 HIGH BLUFF DR SUITE 230, SAN DIEGO, CA 92130

Phone Numbers

858-436-3900

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$1,500,150.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2012-03-30 
$1,500,150.00 
$3,000,300.00 
$1,500,150.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOSEPH 
 
DAVIE, M.D., PH.D. 
DIRECTOR
OCERA THERAPEUTICS INC
LARS 
 
EKMAN, M.D., PH.D. 
DIRECTOR
OCERA THERAPEUTICS INC
LAURENT 
 
FISCHER, M.D. 
EXECUTIVE OFFICER, DIRECTOR
OCERA THERAPEUTICS INC
LINDA 
 
GRAIS, M.D. 
DIRECTOR
OCERA THERAPEUTICS INC
NINA 
 
KJELLSON 
DIRECTOR
LYCERA CORP   |  PRIMERA BIOSYSTEMS INC   |  PRIMERADX, INC.   |  ALVINE PHARMACEUTICALS INC   |  SEQUEL PHARMACEUTICALS INC   |  CNS THERAPEUTICS INC   |  TRIUS THERAPEUTICS INC   |  CEBIX INCOPRATED   |  CEBIX INC   |  EIGER BIOPHARMACEUTICALS INC   |  OCERA THERAPEUTICS INC   |  WELLTOK, INC.   |  OCERA THERAPEUTICS, INC.   |  K2 THERAPEUTICS, INC.   |  CIDARA THERAPEUTICS, INC.   |  EIGER BIOPHARMACEUTICALS, INC.   |  ANNUM HEALTH, INC.   |  VINETI, INC.   |  TYRA BIOSCIENCES, INC.
DANA 
 
MCGOWAN 
EXECUTIVE OFFICER
OCERA THERAPEUTICS INC   |  ONCTERNAL THERAPEUTICS, INC.   |  ARS PHARMACEUTICALS, INC.
MICHAEL 
 
POWELL, PH.D. 
DIRECTOR
OCERA THERAPEUTICS INC   |  DAUNTLESS 1, INC.
PRATIK 
 
SHAH, PH.D. 
DIRECTOR
OCERA THERAPEUTICS INC   |  DESIGN THERAPEUTICS, INC.
ECKARD 
 
WEBER, M.D. 
DIRECTOR
TRAGARA PHARMACEUTICALS INC   |  SONEXA THERAPEUTICS INC   |  NANOTHERA CORP   |  ABREXA PHARMACEUTICALS, INC.   |  OCERA THERAPEUTICS INC   |  SONEXA THERAPEUTICS, INC   |  RIGHTCARE SOLUTIONS, INC.   |  EXALYS THERAPEUTICS, INC.   |  TRANSPOSON THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2012-04-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-03-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#